Ge Long Hui·2025-12-22 11:50Core Viewpoint - The company aims to expand its investment scale, diversify investment risks, accelerate investment pace, and improve investment efficiency through the establishment of the Guangzhou Guangyao Guangkai Venture Capital Fund [1][2] Group 1: Investment Details - The company’s board approved the subscription of limited partnership shares in the Guangzhou Guangyao Guangkai Venture Capital Fund, which is a collaboration with Guangyao Capital and Guangzhou Development Zone Investment Fund Management Co., Ltd [1] - The target scale of the Guangyao Guangkai Fund is 300 million yuan, with an initial fundraising target of 200 million yuan [1] - The Guangyao Phase II Fund plans to invest 97.5 million yuan, accounting for 48.75% of the total, while Guangyao Capital and Guangkai Fund will contribute 2.5 million yuan (1.25%) and 100 million yuan (50%) respectively [1] Group 2: Strategic Implications - This investment aligns with the Guangyao Phase II Fund's investment direction and is expected to strengthen the company's presence in innovative pharmaceuticals, modern traditional Chinese medicine, and high-end medical devices [2] - The strategy of "investing early, investing small, and investing in the future" aims to engage with quality enterprises at their source, fostering and incubating potential companies, thereby accelerating technological upgrades and value chain extensions [2] - The initiative supports the company's transition from a traditional business model to one driven by technological innovation, laying a solid foundation for high-quality development [2]